Hotline for Health Services for Displaced Lebanese 1787
Hotline for the Patient Admission to Hospitals 01/832700
COVID-19 Vaccine Registration Form covax.moph.gov.lb
MoPH Hotline 1214
Are you a new member? Sign up now
 
close

JAKAVI - 20mg - 56

ATC B/G Ingredients code Registration Nb Name Dosage Presentation Form Route Agent Laboratory Country Price Pharmacist Margin Stratum Responsible Party Name Responsible Party Country Exch_date %SUBSIDY
L01EJ01 B Ruxolitinib - 20mg 8001 57514/1 JAKAVI 20mg 56 Tablet Oral Khalil Fattal & Fils S.A.L. Novartis Pharma Stein AG Switzerland 5,153,533 L.L 2.44 E2 Novartis Pharma AG Switzerland 05/02/20

Drugs With Same Ingredients

ATC B/G Ingredients code Registration Nb Name Dosage Presentation Form Route Agent Laboratory Country Price Pharmacist Margin Stratum Responsible Party Name Responsible Party Country Exch_date %SUBSIDY
L01EJ01 G Ruxolitinib - 20mg 11481 152520/1 CELEZON 20mg 56 Tablet Oral Droguerie de l'Union The Arab Pharmaceutical Manufacturing PSC Jordan 3,092,115 L.L 2.44 E2 Hikma Pharmaceuticals Jordan 05/02/20
L01EJ01 B Ruxolitinib - 20mg 8001/945 57514/1 JAKAVI 20mg 56 Tablet Oral Khalil Fattal & Fils S.A.L. Novartis Pharma Stein AG Switzerland 314,193,119 L.L 2.44 E2 Novartis Pharma AG Switzerland 05/02/20 0
L01EJ01 G Ruxolitinib - 20mg 11481/945 152520/1 CELEZON 20mg 56 Tablet Oral Droguerie de l'Union The Arab Pharmaceutical Manufacturing PSC Jordan 188,515,591 L.L 2.44 E2 Hikma Pharmaceuticals Jordan 05/02/20 0
Sitemap
© Copyrights reserved to Ministry of Public Health 2024